Search Results
584 items found for "GPCR therapeutics"
- 📰 GPCR Weekly News, May 13 to 19, 2024
GPCR Board. Tune in and enjoy! Dr. GPCR Matchmaking Meet Mark Schmeizl, our Chief Matchmaker. GPCR Symposia Explore GPCRs with our Premium Membership! GPCR Summit editions. Our symposium on Structural Insights into GPCR Activation is postponed. Mark your calendar for the GPCRs as Therapeutic Targets symposium on October 11th, 2024. GPCR Ecosystem
- 📰 GPCR Weekly News, May 6 to 12, 2024
GPCR Summit. Stay tuned for our next symposium on GPCRs as Therapeutics Targets on October 11th, 2024. ) Antibodies Treated With Therapeutic Plasma Exchange SUCNR1 regulates insulin secretion and glucose signaling pathway networks as cancer therapeutic targets Generation of comprehensive GPCR-transducer-deficient GPCR Ecosystem
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
This technique has uncovered fundamental aspects of the G protein-coupled receptor (GPCR) function, including resurgence in recent times for exploratory analyses to identify previously unknown regions critical to GPCR In summary, mutagenesis can be a critical tool in drug discovery, particularly for studying GPCRs. The directed evolution of ligand specificity in a GPCR and the unequal contributions of efficacy and Molecular determinants of ligand efficacy and potency in GPCR signaling.
- Residency time of agonists does not affect the stability of GPCR-arrestin complexes
September 2022 "Background and purpose: The interaction of arrestins with G-protein coupled receptors (GPCRs GPCRs that internalize without arrestin have been classified as "class A" GPCRs whereas "class B" GPCRs The interaction of arrestins with GPCRs requires both agonist activation and receptor phosphorylation Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly News, May 20 to 26, 2024
GPCR contributor article Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted GPCR University workshop on Advanced Data Analysis for GPCR Pharmacology, led by the esteemed Dr. GPCR Podcast We have thrilling news—Episode 153 of the Dr. GPCR Podcast featuring Dr. Adhesion GPCR Consortium: The 11th Adhesion GPCR Workshop will be held in vibrant Mexico City from October GPCR Ecosystem
- 📰 GPCR Weekly News, April 15 to 21, 2024
Let’s dive into the Classified GPCR News from April 15th to 21st, 2024 GPCR Activation and Signaling in Oncology and Immunology Deciphering a GPCR-lncRNA-miRNA Nexus: Identification of an Aberrant Therapeutic News Addex Therapeutics Reports Full Year 2023 Financial Results And Provides Corporate Update Aelis at the 19th Biopharma Drug Discovery Nexus Salipro Biotech will participate in BioKorea2024 Domain Therapeutics GPCR Ecosystem
- 📰 GPCR Weekly News, April 8 to 14, 2024
Check out our GPCR coverage for this week. GPCR Symposiums and much more! GPCR Partnered Events April 22 - 23, 2024 | Endocrine Metabolic GPCRs Join the Endocrine Metabolic GPCRs Industry News Monash University retains its N° 2 global ranking for Pharmacy and Pharmacology Addex Therapeutics GPCR Ecosystem
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
Hey there, GPCR Enthusiasts! Ready for your GPCR quest, so bold and bright? their behavior for therapeutic benefit. Learn how to therapeutically exploit GPCRs (Physiology’s ‘Swiss Army Knife’) vast repertoire of ways Adjust ligand kinetics and tissue disposition for optimal therapeutic activity. to party with GPCRs next week!
- GRK2 in cardiovascular disease and its potential as a therapeutic target
Thus, identifying novel molecular targets for developing HF therapeutics remains a key research focus G protein-coupled receptors (GPCRs) are critical myocardial signal transducers which regulate cardiac therapeutics currently used in HF target these receptors. A recent focus on GPCR intracellular-regulating proteins such as GPCR kinases (GRKs) has uncovered GRK2 Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly News, April 1 to 7, 2024
GPCR Symposiums and much more! GPCR Partnered Events April 22 - 23, 2024 | Endocrine Metabolic GPCRs Join the Endocrine Metabolic GPCRs signaling in humoral immunity Industry News Neurosterix launches with $63M to Advance Allosteric Modulator Therapeutics Financial Resultsand Confirms Its 2024 Outlook Sosei Heptares officially changed their name to Nxera Domain Therapeutics GPCR Ecosystem
- 📰 GPCR Weekly News, April 22 to 28, 2024
Check out our GPCR coverage for this week. GPCR University hands-on workshop with Dr. GPCR Symposia Join us on June 7th for our symposium on Structural and Molecular Insights into GPCR Function Let’s dive into the Classified GPCR News from April 22nd to 28th, 2024 Adhesion GPCRs Dysfunction of GPCR Ecosystem
- Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization
regulating the dynamics of the serotonin1A receptor, a crucial neurotransmitter G protein-coupled receptor (GPCR in understanding the modulatory role of the membrane environment on the organization and dynamics of GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly News, March 18 to 24, 2024
Check out our GPCR coverage for this week. We have 15 GPCR papers and four industry news. GPCR Symposium on GPCR activation and signaling sessions. GPCR Partnered Events April 22 - 23, 2024 | Endocrine Metabolic GPCRs Join the Endocrine Metabolic GPCRs Subject in Phase 1 Trial with HTL0033744, an EP4 Agonist for Inflammatory Bowel Disease (IBD) Domain Therapeutics GPCR Ecosystem
- 📰 GPCR Weekly News, March 11 to 17, 2024
GPCR Symposium on GPCR activation and signaling a resounding success! GPCR Partnered Events April 22 - 23, 2024 | Endocrine Metabolic GPCRs Join the Endocrine Metabolic GPCRs Function Time-resolved cryo-EM of G-protein activation by a GPCR Industry News Domain Therapeutics and mayo controls midgut development in Drosophila Karuna Therapeutics announces that is now part of Bristol GPCR Ecosystem
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
activity without directly competing with ligands, potentially reducing side effects and increasing therapeutic the findings of this study have significant implications for drug design, personalised medicine, and therapeutic Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery. Dr. GPCR Ecosystem; Dr. GPCR Ecosystem. https://www.ecosystem.drgpcr.com/post/decoding-gpcr-function-the-role-of-mutagenesis-in-rational-drug-discovery Molecular determinants of ligand efficacy and potency in GPCR signaling.
- 📰 GPCR Weekly News, February 19 to 25, 2024
Check out our GPCR coverage for this week. GPCR Symposia Mark your calendars! April 22 - 23, 2024 | Endocrine Metabolic GPCRs Join Dr. GPCR Founder Dr. Binders, Drugs, and more Advances in structure-based drug design: The potential for precision therapeutics GPCR Ecosystem
- 📰 GPCR Weekly News, February 5 to 11, 2024
Check out our GPCR coverage for this week. GPCR Symposia Our upcoming symposium on March 15th is about GPCR activation and signaling. Let’s dive into the Classified GPCR News from February 5th to 11th, 2024 GPCR Activation and Signaling Fourth Quarter and Fiscal 2023 Financial Results and Provides Financial Expectations for 2024 Domain Therapeutics GPCR Ecosystem
- 📰 GPCR Weekly News, March 4 to 10, 2024
GPCR Symposia TOMORROW, we are hosting a symposium on GPCR activation and signaling. GPCR Partnered Events April 22 - 23, 2024 | Endocrine Metabolic GPCRs Join the Endocrine Metabolic GPCRs Let’s dive into the Classified GPCR News from March 4th to 10th, 2024 GPCR Activation and Signaling Glu1022.53 Deciphering the role of GPCRs in obesity pathology for drug development GPCR Events, Meetings, and Webinars GPCR Ecosystem
- 📰 GPCR Weekly News, January 22 to 28, 2024
Xavier Leroy on his appointment as CEO of GIO Therapeutics! Congratulations to Domain Therapeutics for being awarded the RHU SPRINT consortium grant. Cardiovascular Health and its Therapeutic Implications The perspective of cAMP/cGMP signaling and cyclic Living Cells with Cucurbit[7]uril and Hemicyanine as a "Turn-On" Fluorescence Probe Industry News Domain Therapeutics Xavier Leroy appointed as CEO of GIO Therapeutics GPCR Events, Meetings, and Webinars NOW!
- 📰 GPCR Weekly News, February 12 to 18, 2024
We are thrilled to present our comprehensive GPCR coverage for the week; we have 14 GPCR papers, six GPCR Symposia Our upcoming symposium on March 15th is about GPCR activation and signaling. GPCR Partnered Events March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit Join us at the 3rd April 22 - 23, 2024 | Endocrine Metabolic GPCRs Join Dr. GPCR founder Dr. GPCR Ecosystem
- 📰 GPCR Weekly News, January 8 to 14, 2024
Dive into our GPCR coverage for this week! We’ve curated 10 GPCR papers, seven industry news, and two GPCR job ads! This week's highlight: Dr. GPCR University February 8 - 29: Join Dr. GPCR University's live course with Dr. Terry Kenakin. , and more The multifaceted functions of β-arrestins and their therapeutic potential in neurodegenerative GPCR Ecosystem
- 📰 GPCR Weekly News, January 1 to 7, 2024
We’ve curated 18 GPCR papers, 8 industry news, and 2 GPCR job offers! Congratulations to Domain Therapeutics for appointing Michael Gottlieb as Chairman and Dr. states Reviews, GPCRs, and more G Protein-coupled Receptors (GPCRs) as Potential Therapeutics for Psychiatric modulate engagement of CCR5 by chemokines by removing key electrostatic interactions Industry News Domain Therapeutics GPCR Ecosystem
- 📰 GPCR Weekly News, December 18 to 31, 2023
We’ve curated 23 GPCR papers, four industry news, and 3 GPCR job posts! This week's highlight: Drs. GPCR Ecosystem Members! GPCR Access to Dr. Morgan Healthcare Conference Andrew Hopkins appointed CBE by HM King Charles III Voyager Therapeutics GPCR Ecosystem
- 📰 GPCR Weekly News, January 15 to 21, 2024
Check out our curated GPCR coverage for this week, which includes 14 GPCR papers, four industry news, one GPCR Event, and two GPCR job ads! GPCR University Our first Dr. GPCR at the Endocrine Metabolic GPCRs Summit on April 22-23, 2024, in Birmingham, UK. Dr. GPCR Ecosystem
- 📰 GPCR Weekly News, June 3 to June 9, 2024
Adhesion GPCR Consortium: The 11th Adhesion GPCR Workshop. Adhesion GPCRs A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets Services and Cube Biotech Collaborate to Enhance Cryo-EM Enabled Gene to Structure Workflow Domain Therapeutics ACTH-Dependent Cushing’s Syndrome (ADCS) Septerna Presents Preclinical Data at ENDO 2024 Highlighting Therapeutic GPCR Ecosystem
- 📰 GPCR Weekly News, May 27 to June 2, 2024
GPCR Podcast Episode 154 of the Dr. tunes mGlu5 receptor function, impacting synaptic transmission Orphan receptor GPR88 as a potential therapeutic the neuropeptide Y4 receptor and its ligand pancreatic polypeptide from a structural, functional, and therapeutic News Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule GPCR Ecosystem
- 📰 GPCR Weekly News, December 4 to 10, 2023
Hi GPCR lovers! GPCR University live Zoom sessions hosted by Dr. Terry Kenakin. , and more Structure, function and drug discovery of GPCR signaling Illuminating the understudied GPCR-ome Muscarinic Agonist Candidates in Phase 1 Clinical Studies AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics GPCR Ecosystem
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future
October 2022 "Cannabinoid Receptor 2 (CB2) is a G protein-coupled receptor (GPCR) with considerable, though as yet unrealised, therapeutic potential. Read more at the source #DrGPCR #GPCR #IndustryNews